{"id":"W2062156425","doi":"10.1111/jcpt.12044","title":"Biological treatments for moderate-to-severe psoriasis: indirect comparison","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Pharmacy and Therapeutics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Medicine; Etanercept; Infliximab; Adalimumab; Psoriasis; Clinical trial; Placebo; Randomized controlled trial; Internal medicine; Dermatology; Disease; Rheumatoid arthritis; Pathology; Alternative medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006227378,0.000218406,0.0008316275,0.00008385604,0.0001422861,0.00003304615,0.0001940927,0.0002196392,0.0002235873],"category_scores_gemma":[0.00009131522,0.0001385057,0.000333541,0.00007894248,0.0001021016,0.0001271826,0.00003464832,0.0002881114,0.0001245423],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001684664,"about_ca_system_score_gemma":0.00006247556,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006865808,"about_ca_topic_score_gemma":0.000001125157,"domain_scores_codex":[0.9979659,0.0003872897,0.001096208,0.0002114847,0.00004970891,0.0002894014],"domain_scores_gemma":[0.9979436,0.001140536,0.0004897047,0.0001192925,0.0001989923,0.0001078061],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.006346893,0.001516796,0.1142982,0.00001003068,0.004706162,0.000005675174,0.0003612553,0.00001293893,0.008488786,0.0000798539,0.003351439,0.860822],"study_design_scores_gemma":[0.06653271,0.009750838,0.2118098,0.0001423036,0.004821853,0.0003459125,0.0005636397,0.0003522136,0.06771108,0.007813299,0.6290835,0.001072801],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909604,0.005453013,0.0003497872,0.0008570616,0.001681026,0.0004503886,0.00003418701,0.00001849544,0.0001956528],"genre_scores_gemma":[0.9939163,0.002909279,0.001018906,0.001355733,0.0003028624,0.00002310159,0.00001581076,0.00001549421,0.0004425048],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8597491,"threshold_uncertainty_score":0.56481,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1947639593448097,"score_gpt":0.4227878923769198,"score_spread":0.2280239330321101,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}